Costo-Efectividad De Exploración De Miembros Pélvicos Para Prevenir Pie Diabético

Diabetic neuropathy is a common and frequent complication of DM2. It is the main risk factor for ulcer and amputation of lower limbs. The risk of developing ulcer foot is 12 -25%. In the first level of care medical, history and physical examination of the patient with DM2 is performed to determine the appropriate treatment. Objective: Determine the costeffectiveness of the exploration of pelvic limbs to prevent diabetic foot. Materials and Methods: Cost-effectiveness design. Clinical records of patients with DM2. Sample calculation with the formula of percentages of two populations. Group 1, complete scan of pelvic limbs (n=15) and Group 2 with incomplete examination of lower limbs (n=40). Sociodemographic variables, health characteristics, type and number of laboratory studies requested, type and quantity of drugs prescribed were analyzed. The effectiveness was evaluated as absence of data from diabetic foot in five years follow- up. The cost of care was estimated with the profile of use and unit cost. Statistical analysis averages, percentages and cost-effectiveness. Results: The total cost in group 1 was $7,203.24 and$4,909.03 in 2. Group 1, the total cost in laboratory studies was $5,863.44,$ 187.62 in drugs and average cost of $1,152.18 in consultation; while in the 2, laboratory it was$ 3,596.76 , $186.24 medicines and average cost of consultation$ 1,126.03. The effectiveness for $5,000.00 in group 1 corresponds to$ 37.00 and in the group 2 to $79.75. Conclusions: It was no scanning showed that full pelvic limbs and timely detection of diabetic foot out cost-effective

Correlación Mastográfica E Histopatológica En Lesiones De Mama No Palpables

Globally, breast cancer ranks first in malignancies. It affects women over 40 years. An early diagnosis of no-palpable lesions, in sub-clinical stages, increases the probability of detecting at an early stage with increase survival and disease-free interval. Objective: To determine the correlation between mammography and histopatological lesions non palpable breast. Material and Methods: Study with correlational design. Histopathological records in women with non-palpable lesions and mamography of the Mexican Social Security Institute, Querétaro, Mexico from 2011-2013. Sample size for correlational studies. Data obtained from the medical records of women with mammography BI-RADS 2 to 5 and confirmatory histopathology. Variables analized: sociodemographic data, family history of breast cáncer, histopathological diagnosis and mammography with BIRADS. Descriptive statistical analysis. X2 test and Cramer correlation with confidence level of 95%. Results: 44 cases were analyzed. The average age of women was 52.04 ± años (IC 95%: 40.9 - 63.2). Predominant group of 56 to 70 years, 47.7 % (IC 95%: 36.5-58.9). Diagnosis with breast cancer 22.7% (IC 95%: 13.3 - 32.1), BI-RADS 2 in 4.5% (IC 95%: 0 - 9.1), BIRADS 3 in 29.5% (IC 95%: 19.3 - 39.7), BI-RADS 4 in 56.9% (IC 95%: 45.8 - 68.0) BI-RADS 5 in 9.1% (IC 95%: 2.7 - 15.5). The correlation between mammography and histopathological diagnosis was 0.26, p = 0.43. Conclusions: There was a low, no significant correlation, likely to include women with BI-RADS in early stage